BCD Kit using blood sample,
developed first in the world with ROK-Government R&D funding since 2007.
Currently, the main methods of
breast cancer detection were X-Ray, ultrasonic waves and direct biopsy with
only 50 ~ 60% accuracy.
Biopsy is not cost effective and
inconvenient, hence BCD Kit is the most cost effective and pain free
BCD kit is the one and only in the
world that is groundbreaking and shows 92% or more of sensitivity and
specificity even with a small amount of sample blood of a patient.
BCD, a simple primary screening
tool for breast cancer.
BCD kit was developed by E&S
Healthcare in local Biotech company, Biocurepharm Inc.
is the global marketing partner.
A new joint
currently acquired CE marking on BCD Kit.